SOMNOMED LIMITED - Announcements

Market Cap $95.08M Add to my watchlist

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling... SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Company’s segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

SOM	Results of Meeting		26/11/14	Share
SOM	Investor Presentation		10/11/14	Share
SOM	SomnoMed exceeds 200,000 patients	PRICE SENSITIVE	10/11/14	Share
SOM	Annual General Meeting Proxy Form		23/10/14	Share
SOM	Notice of Annual General Meeting		23/10/14	Share
SOM	Appendix 3B		21/10/14	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	16/10/14	Share
SOM	New records in September confirm guidance	PRICE SENSITIVE	16/10/14	Share
SOM	Annual Report to shareholders		30/09/14	Share
SOM	US Medicare approval for SomnoMed Herbst Advance		23/09/14	Share
SOM	Change of Director's Interest Notice		22/08/14	Share
SOM	Change of Director's Interest Notice		22/08/14	Share
SOM	Appendix 3B		22/08/14	Share
SOM	Share Purchase Plan closes oversubscribed		22/08/14	Share
SOM	Investor Presentation		21/08/14	Share
SOM	Preliminary Final Report	PRICE SENSITIVE	21/08/14	Share
SOM	Change in substantial holding		12/08/14	Share
SOM	Section 708A Notice		08/08/14	Share
SOM	Appendix 3B		08/08/14	Share
SOM	Share Placement update		08/08/14	Share
SOM	Notice in accordance with ASIC Class Order 09/425		31/07/14	Share
SOM	Share Purchase Plan application form		30/07/14	Share
SOM	Share Purchase Plan Offer and Rules	PRICE SENSITIVE	30/07/14	Share
SOM	Share Placement and 2014 Share Purchase Plan	PRICE SENSITIVE	25/07/14	Share
SOM	Trading Halt	PRICE SENSITIVE	24/07/14	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	23/07/14	Share
SOM	New sales records in Q4 & increasing growth prospects14/15	PRICE SENSITIVE	23/07/14	Share
SOM	Appendix 3B		22/07/14	Share
SOM	SomnoMed takes over Italian Distribution	PRICE SENSITIVE	10/07/14	Share
SOM	SomnoMed USA receives 510K for Somnodent Fusion	PRICE SENSITIVE	24/06/14	Share
SOM	SomnoMed launches two new products in USA		03/06/14	Share
SOM	SomnoMed starts business in Spain and Portugal	PRICE SENSITIVE	26/05/14	Share
SOM	SomnoMed enters UK - Ireland market	PRICE SENSITIVE	16/05/14	Share
SOM	Appendix 3B		06/05/14	Share
SOM	SomnoMed commences business in Finland	PRICE SENSITIVE	01/05/14	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	10/04/14	Share
SOM	SomnoMed achieves 28% volume growth in Q3	PRICE SENSITIVE	10/04/14	Share
SOM	Ceasing to be a substantial holder		24/03/14	Share
SOM	Change in substantial holding		07/03/14	Share
SOM	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/14	Share
SOM	Investor Presentation		26/02/14	Share
SOM	Investor Presentation Webcast details		24/02/14	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	16/01/14	Share
SOM	SomnoMed accelerates growth in Q2	PRICE SENSITIVE	16/01/14	Share
SOM	Appendix 3B		22/11/13	Share
SOM	Results of Meeting		21/11/13	Share
SOM	SomnoMed exceeds 150,000 patients wordwide	PRICE SENSITIVE	21/11/13	Share
SOM	Appendix 3B		14/11/13	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/13	Share
SOM	First Quarter Results confirm Growth Path		25/10/13	Share
SOM	Annual General Meeting Proxy Form		21/10/13	Share
SOM	Notice of Annual General Meeting		21/10/13	Share
SOM	SomnoMed expands in Korea	PRICE SENSITIVE	17/10/13	Share
SOM	Appendix 3B		04/10/13	Share
SOM	Annual Report to shareholders		25/09/13	Share
SOM	Investor Presentation		25/09/13	Share
SOM	Preliminary Final Report	PRICE SENSITIVE	27/08/13	Share
SOM	SomnoMed US Medical Advisory Board formed		24/07/13	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	19/07/13	Share
SOM	SomnoMed posts strong cash position	PRICE SENSITIVE	19/07/13	Share
SOM	Appendix 3B		18/07/13	Share
SOM	SomnoMed acquires Orthosleep19 in Germany	PRICE SENSITIVE	04/07/13	Share
SOM	SomnoMed breaks through 10,000 unit sales in 4th Quarter	PRICE SENSITIVE	02/07/13	Share
SOM	Progress in USA	PRICE SENSITIVE	12/06/13	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	12/04/13	Share
SOM	Strong European growth and new US management team in place	PRICE SENSITIVE	12/04/13	Share
SOM	SomnoMed appoints Chief Medical Officer		04/03/13	Share
SOM	Investor presentation		28/02/13	Share
SOM	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/13	Share
SOM	Significant expansion of SomnoMed US management team		25/02/13	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/13	Share
SOM	SomnoMed delivers a record Second Quarter	PRICE SENSITIVE	30/01/13	Share
SOM	Appendix 3B		07/01/13	Share
SOM	Becoming a substantial holder		27/12/12	Share
SOM	SomnoMed acquires MAS Nordic	PRICE SENSITIVE	14/12/12	Share
SOM	Compliance measurement - exclusive agreement signed	PRICE SENSITIVE	11/12/12	Share
SOM	Appendix 3B		06/12/12	Share
SOM	Change in substantial holding		05/12/12	Share
SOM	Acquisition of Orthosom in France completed	PRICE SENSITIVE	03/12/12	Share
SOM	Change of Director's Interest Notice		22/11/12	Share
SOM	Change of Director's Interest Notice		22/11/12	Share
SOM	Change of Director's Interest Notice		22/11/12	Share
SOM	Appendix 3B		21/11/12	Share
SOM	Results of Meeting		21/11/12	Share
SOM	Appendix 3B		26/10/12	Share
SOM	Continuing Global Growth for SomnoMed		22/10/12	Share
SOM	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/12	Share
SOM	Response to ASX Corporate Governance Query		19/10/12	Share
SOM	Notice of Annual General Meeting-updated		16/10/12	Share
SOM	Proxy Form Annual General Meeting		16/10/12	Share
SOM	Notice of Annual General Meeting		16/10/12	Share
SOM	Acquisition of 2nd largest oral appliance company in France	PRICE SENSITIVE	09/10/12	Share
SOM	Appendix 3B		03/10/12	Share
SOM	Becoming a substantial holder		02/10/12	Share
SOM	Annual Report to shareholders		28/09/12	Share
SOM	Appointment Head of North American region		27/09/12	Share
SOM	Appointment VP Managed Care North America		24/09/12	Share
SOM	Partnership with Burkhart Dental Supply	PRICE SENSITIVE	12/09/12	Share
SOM	Appendix 3B		11/09/12	Share
SOM	Investor Presentation		31/08/12	Share

SOM Results of Meeting
26/11/14		Share
SOM Investor Presentation
10/11/14		Share
SOM SomnoMed exceeds 200,000 patients
10/11/14	PRICE SENSITIVE	Share
SOM Annual General Meeting Proxy Form
23/10/14		Share
SOM Notice of Annual General Meeting
23/10/14		Share
SOM Appendix 3B
21/10/14		Share
SOM Appendix 4C - quarterly
16/10/14	PRICE SENSITIVE	Share
SOM New records in September confirm guidance
16/10/14	PRICE SENSITIVE	Share
SOM Annual Report to shareholders
30/09/14		Share
SOM US Medicare approval for SomnoMed Herbst Advance
23/09/14		Share
SOM Change of Director's Interest Notice
22/08/14		Share
SOM Change of Director's Interest Notice
22/08/14		Share
SOM Appendix 3B
22/08/14		Share
SOM Share Purchase Plan closes oversubscribed
22/08/14		Share
SOM Investor Presentation
21/08/14		Share
SOM Preliminary Final Report
21/08/14	PRICE SENSITIVE	Share
SOM Change in substantial holding
12/08/14		Share
SOM Section 708A Notice
08/08/14		Share
SOM Appendix 3B
08/08/14		Share
SOM Share Placement update
08/08/14		Share
SOM Notice in accordance with ASIC Class Order 09/425
31/07/14		Share
SOM Share Purchase Plan application form
30/07/14		Share
SOM Share Purchase Plan Offer and Rules
30/07/14	PRICE SENSITIVE	Share
SOM Share Placement and 2014 Share Purchase Plan
25/07/14	PRICE SENSITIVE	Share
SOM Trading Halt
24/07/14	PRICE SENSITIVE	Share
SOM Appendix 4C - quarterly
23/07/14	PRICE SENSITIVE	Share
SOM New sales records in Q4 & increasing growth prospects14/15
23/07/14	PRICE SENSITIVE	Share
SOM Appendix 3B
22/07/14		Share
SOM SomnoMed takes over Italian Distribution
10/07/14	PRICE SENSITIVE	Share
SOM SomnoMed USA receives 510K for Somnodent Fusion
24/06/14	PRICE SENSITIVE	Share
SOMSomnoMed launches two new products in USA
03/06/14		Share
SOMSomnoMed starts business in Spain and Portugal
26/05/14	PRICE SENSITIVE	Share
SOMSomnoMed enters UK - Ireland market
16/05/14	PRICE SENSITIVE	Share
SOMAppendix 3B
06/05/14		Share
SOMSomnoMed commences business in Finland
01/05/14	PRICE SENSITIVE	Share
SOMAppendix 4C - quarterly
10/04/14	PRICE SENSITIVE	Share
SOMSomnoMed achieves 28% volume growth in Q3
10/04/14	PRICE SENSITIVE	Share
SOMCeasing to be a substantial holder
24/03/14		Share
SOMChange in substantial holding
07/03/14		Share
SOMHalf Yearly Report and Accounts
26/02/14	PRICE SENSITIVE	Share
SOMInvestor Presentation
26/02/14		Share
SOMInvestor Presentation Webcast details
24/02/14		Share
SOMAppendix 4C - quarterly
16/01/14	PRICE SENSITIVE	Share
SOMSomnoMed accelerates growth in Q2
16/01/14	PRICE SENSITIVE	Share
SOMAppendix 3B
22/11/13		Share
SOMResults of Meeting
21/11/13		Share
SOMSomnoMed exceeds 150,000 patients wordwide
21/11/13	PRICE SENSITIVE	Share
SOMAppendix 3B
14/11/13		Share
SOMAppendix 4C - quarterly
25/10/13	PRICE SENSITIVE	Share
SOMFirst Quarter Results confirm Growth Path
25/10/13		Share
SOMAnnual General Meeting Proxy Form
21/10/13		Share
SOMNotice of Annual General Meeting
21/10/13		Share
SOMSomnoMed expands in Korea
17/10/13	PRICE SENSITIVE	Share
SOMAppendix 3B
04/10/13		Share
SOMAnnual Report to shareholders
25/09/13		Share
SOMInvestor Presentation
25/09/13		Share
SOMPreliminary Final Report
27/08/13	PRICE SENSITIVE	Share
SOMSomnoMed US Medical Advisory Board formed
24/07/13		Share
SOMAppendix 4C - quarterly
19/07/13	PRICE SENSITIVE	Share
SOMSomnoMed posts strong cash position
19/07/13	PRICE SENSITIVE	Share
SOMAppendix 3B
18/07/13		Share
SOMSomnoMed acquires Orthosleep19 in Germany
04/07/13	PRICE SENSITIVE	Share
SOMSomnoMed breaks through 10,000 unit sales in 4th Quarter
02/07/13	PRICE SENSITIVE	Share
SOMProgress in USA
12/06/13	PRICE SENSITIVE	Share
SOMAppendix 4C - quarterly
12/04/13	PRICE SENSITIVE	Share
SOMStrong European growth and new US management team in place
12/04/13	PRICE SENSITIVE	Share
SOMSomnoMed appoints Chief Medical Officer
04/03/13		Share
SOMInvestor presentation
28/02/13		Share
SOMHalf Yearly Report and Accounts
26/02/13	PRICE SENSITIVE	Share
SOMSignificant expansion of SomnoMed US management team
25/02/13		Share
SOMAppendix 4C - quarterly
30/01/13	PRICE SENSITIVE	Share
SOMSomnoMed delivers a record Second Quarter
30/01/13	PRICE SENSITIVE	Share
SOMAppendix 3B
07/01/13		Share
SOMBecoming a substantial holder
27/12/12		Share
SOMSomnoMed acquires MAS Nordic
14/12/12	PRICE SENSITIVE	Share
SOMCompliance measurement - exclusive agreement signed
11/12/12	PRICE SENSITIVE	Share
SOMAppendix 3B
06/12/12		Share
SOMChange in substantial holding
05/12/12		Share
SOMAcquisition of Orthosom in France completed
03/12/12	PRICE SENSITIVE	Share
SOMChange of Director's Interest Notice
22/11/12		Share
SOMChange of Director's Interest Notice
22/11/12		Share
SOMChange of Director's Interest Notice
22/11/12		Share
SOMAppendix 3B
21/11/12		Share
SOMResults of Meeting
21/11/12		Share
SOMAppendix 3B
26/10/12		Share
SOMContinuing Global Growth for SomnoMed
22/10/12		Share
SOMAppendix 4C - quarterly
22/10/12	PRICE SENSITIVE	Share
SOMResponse to ASX Corporate Governance Query
19/10/12		Share
SOMNotice of Annual General Meeting-updated
16/10/12		Share
SOMProxy Form Annual General Meeting
16/10/12		Share
SOMNotice of Annual General Meeting
16/10/12		Share
SOMAcquisition of 2nd largest oral appliance company in France
09/10/12	PRICE SENSITIVE	Share
SOMAppendix 3B
03/10/12		Share
SOMBecoming a substantial holder
02/10/12		Share
SOMAnnual Report to shareholders
28/09/12		Share
SOMAppointment Head of North American region
27/09/12		Share
SOMAppointment VP Managed Care North America
24/09/12		Share
SOMPartnership with Burkhart Dental Supply
12/09/12	PRICE SENSITIVE	Share
SOMAppendix 3B
11/09/12		Share
SOMInvestor Presentation
31/08/12		Share

REFRESH

First 2 3 4

(20min delay)
Last 29.0¢		Change 0.000(0.00%)		Mkt cap ! $95.08M

Open	High	Low	Value	Volume
29.0¢	29.5¢	29.0¢	$7.157K	24.43K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	28.0¢

Sellers (Offers)

Price($)	Vol.	No.
29.0¢	3200	1

View Market Depth

No.	Vol.	Price($)
1	2500	1.490
1	690	1.450
1	487	1.410
1	513	1.370
1	1500	1.195

Price($)	Vol.	No.
1.760	188	1
1.950	2701	2
1.990	10000	1
2.000	1637	1
2.100	2500	1

Last trade - 10.37am 15/11/2024 (20 minute delay)


Last 29.0¢		Change 0.000 ( 1.75 %)
Open	High	Low	Volume
28.5¢	29.0¢	28.5¢	6638
Last updated 10.19am 15/11/2024 ?

SOM (ASX) Chart